Felix-Julian Campos-Garcia

Dr. Felix-Julian Campos-Garcia

Mexican Social Security Institute, Mexico City, Ciudad de México, Mexico
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2017 in Journal of Medical Screening
Verified
Journal Article
Closed access
IIIsabel Ibarra-González
Isabel Ibarra-González
FCFelix-Julian Campos-Garcia
Felix-Julian Campos-Garcia
LHLuz del Alba Herrera-Pérez
Luz del Alba Herrera-Pérez
PMPatricia Martínez-Cruz
Patricia Martínez-Cruz
CMClaudia-Margarita Moreno-Graciano
Claudia-Margarita Moreno-Graciano
Marcela Vela-AmievaMarcela Vela-Amieva
Marcela Vela-Amieva
To use the results of the first five years of a cystic fibrosis newborn screening program to estimate the cystic fibrosis birth prevalence and spectrum of cystic fibrosis transmembrane conductance regulator (CFTR) gene variants in Yucatan, Mexico. Screening was performed from 2010 to 2015, using two-tier immunoreactive trypsinogen testing, followed by a sweat test. When sweat test values were >30 mmol/L, the CFTR gene was analyzed. Of 96,071 newborns screened, a second sample was requested in 119 cases. A sweat test was performed in 30 newborns, and 9 possible cases were detected (seven confirmed cystic fibrosis and two inconclusive). The most frequently detected CFTR pathogenic variant (5/14 cystic fibrosis alleles, 35.7%) was p.(Phe508del); novel p.(Ala559Pro) and p.(Thr1299Hisfs*29) pathogenic variants were found. Cystic fibrosis birth prevalence in southeastern Mexico is 1:13,724 newborns. Immunoreactive trypsinogen blood concentration is influenced by gestational age and by the time of sampling. The spectrum of CFTR gene variants in Yucatan is heterogeneous.

22 August 2022 in Cardiogenetics
Verified
Journal Article
Open access
PDF file
FCFelix-Julian Campos-Garcia
Felix-Julian Campos-Garcia
ACAddy-Manuela Castillo-Espinola
Addy-Manuela Castillo-Espinola
CMCarolina-Elizabeth Medina-Escobedo
Carolina-Elizabeth Medina-Escobedo
JZJuan C. Zenteno
Juan C. Zenteno
JLJulio Lara
Julio Lara
AVAna-Isabel Velazquez-Ibarra
Ana-Isabel Velazquez-Ibarra
22q11.2 deletion syndrome is a phenotypic spectrum that encompasses DiGeorge syndrome (OMIM: 188400) and velocardiofacial syndrome (OMIM: 192430). It is caused by a 1.5–3.0 Mb hemizygous deletion of locus 22q11.2, which leads to characteristic facies, conotruncal cardiovascular malformations, velopharyngeal insufficiency, T-lymphocyte dysfunction due to thymic aplasia, and parathyroid hypoplasia, and, less frequently, neurological manifestations such as delayed psychomotor development or schizophrenia. This study aimed to describe a screening method for the diagnosis of 22q11.2 deletion syndrome in patients with Conotruncal Congenital Heart Disease (CCHD), using qPCR to detect the copy number of the TBX1 gene in a single DNA sample. A total of 23 patients were included; 21 with a biallelic prediction of the TBX1 copy number gene and 2 with a monoallelic prediction who were suspected to be positive and subjected to MLPA confirmation. One patient (4.34%) with truncus arteriosus CCHD was confirmed to have 22q11.2 deletion syndrome. We propose this approach as a possible newborn screening method for 22q11.2 deletion syndrome in CCHD patients.

1 December 2019 in Molecular Genetics and Metabolism Reports
Verified
Journal Article
Open access
FCFelix-Julian Campos-Garcia
Felix-Julian Campos-Garcia
OCOscar F. Chacon-Camacho
Oscar F. Chacon-Camacho
SCSilvina Contreras-Capetillo
Silvina Contreras-Capetillo
MCMarisa Cruz-Aguilar
Marisa Cruz-Aguilar
CMCarolina E. Medina-Escobedo
Carolina E. Medina-Escobedo
JZJuan C. Zenteno
Juan C. Zenteno
Biallelic mutations of the GCDH gene result in Glutaric Aciduria type 1 (GA1; OMIM #231670), an uncommon autosomal recessive inborn error caused by the deficiency of glutaryl-CoA dehydrogenase (CCDH), a mitochondrial matrix protein involved in the degradation of l-lysine, L-hydroxylysine, and L-tryptophan. The enzymatic deficiency leads to the accumulation of neurotoxins causing macrocephaly at birth, hypotonia and dystonia due to bilateral striatal injury, that evolves with aging, if untreated, to fixed dystonia and akinetic-rigid parkinsonism. In this article, we describe the results of molecular studies of 5 unrelated patients with GA1 in Southern Mexico. Mutational analysis identified 2 novel likely pathogenic GCDH variants (p.Leu130Pro and p.Gly391Val), 1 pathogenic variant that is predicted to cause a premature stop codon (p.Leu370*), and 2 previously reported pathogenic variants (p.Arg294Trp and p.Arg294Gln). The recurrence of the p.Leu130Pro variant (60% of mutant alleles) suggested a possible founder mutation effect. Our results expand the mutational spectrum in GA1 patients and support the importance of early diagnosis through newborn screening that promotes early nutritional treatment and prevents metabolic crisis. Glutaric Aciduria type 1 has a wide mutational spectrum; the p.Leu130Pro variant may be a founder mutation in Southeast Mexico.

1 December 2015 in Clinical Biochemistry
Verified
Journal Article
Closed access
VVVanessa Villegas-Ruíz
Vanessa Villegas-Ruíz
FCFelix-Julian Campos-Garcia
Felix-Julian Campos-Garcia
SCSilvina Contreras-Capetillo
Silvina Contreras-Capetillo
CMClaudia M. Moreno-Graciano
Claudia M. Moreno-Graciano
FMFelipe A. Maldonado-Solis
Felipe A. Maldonado-Solis
JZJuan C. Zenteno
Juan C. Zenteno

23 April 2025 in Cardiogenetics
Verified
Journal Article
Open access
PDF file
SCSandra Rodriguez Cambranis
Sandra Rodriguez Cambranis
ACAddy-Manuela Castillo-Espinola
Addy-Manuela Castillo-Espinola
CFClaudia-Daniela Fuentelzas-Rosado
Claudia-Daniela Fuentelzas-Rosado
PSPaulina Salazar-Sansores
Paulina Salazar-Sansores
CNClaudia-Gabriela Nuñez-Solis
Claudia-Gabriela Nuñez-Solis
FCFelix-Julian Campos-Garcia
Felix-Julian Campos-Garcia
Ellis-van Creveld syndrome (EvC) is a rare genetic disorder (7:10,000,000) caused by biallelic pathogenic variants in EVC and EVC2, which are located in close proximity on chromosome 4p16.2 in a divergent orientation. These genes encode ciliary complex proteins essential for Hedgehog signaling. EvC is characterized by congenital heart disease (CHD), postaxial polydactyly, and rhizomelic shortening. We present a case of a female newborn from southeast Mexico carrying a novel missense variant in EVC, which is aligned with a systematic review aimed at exploring genotype–phenotype correlations in EVC-related EvC. A PRISMA-based systematic review was conducted in PubMed, Web of Science, and OVID/Medline (until December 2024). Studies reporting EVC variants in EvC were included. Data extraction and quality assessment were performed independently by four reviewers, and genotype–phenotype correlation analysis was conducted. Fifteen studies (n = 66 patients) met the inclusion criteria. The most prevalent features were postaxial polydactyly (95.5%), nail hypoplasia (68.2%), and CHD (66.7%) with atrioventricular canal as the most frequent subtype. Fifty-five distinct EVC variants across 132 alleles were identified, predominantly affecting the N-terminal region (first 699 amino acids). They were syndactyly correlated with pathogenic variants in exons 6, 12, and 13, which were proximal to the second and third coiled-coil domains. This review confirms the key clinical features of EVC-related EvC and highlights genetic heterogeneity. The correlation between syndactyly and specific exonic variants suggests potential genotype–phenotype associations, warranting further functional studies.

1 January 2024 in Sage Open Medical Case Reports
Verified
Journal Article
Open access
HRHenry-Marcelo Rodriguez-Perez
Henry-Marcelo Rodriguez-Perez
OROlga-Berenice Reyes-Flores
Olga-Berenice Reyes-Flores
YQYazmin Quiñonez-Pacheco
Yazmin Quiñonez-Pacheco
YCYahir-Arturo Centeno-Navarrete
Yahir-Arturo Centeno-Navarrete
CGCruz Gonzalez-Vazquez
Cruz Gonzalez-Vazquez
FCFelix-Julian Campos-Garcia
Felix-Julian Campos-Garcia
Pantothenate kinase-associated neurodegeneration (PKAN, OMIM: 234200) results from biallelic pathogenic variants in PANK2 which encodes pantothenate kinase 2, a crucial mitochondrial enzyme involved in coenzyme A biosynthesis. Pantothenate kinase-associated neurodegeneration patients typically exhibit the distinctive “eye of the tiger” sign on brain magnetic resonance imaging in the globus pallidus, along with psychiatric symptoms, extrapyramidal movements such as parkinsonism and dystonia, eventual speech and gait impairments, and the presence of dysphagia. An 11-year-old girl, with fifth-degree consanguinity, demonstrated typical psychomotor development and growth until the age of 5, when she began experiencing psychiatric symptoms. At the age of 9, she developed hand tremors, progressing to generalized muscular dystonia. By age 10, she exhibited gait and speech impairment. Physical examination revealed extensive generalized dystonia, hand tremors, speech impairment, dysphagia, inability to walk, and heightened osteotendinous reflexes. Metabolic analysis identified dyslipidemia with partial response to statin treatment and normocalcemic hypercalciuria. Exome sequencing revealed a novel likely pathogenic variant in PANK2 (NM_001386393.1:c.526C > G) in a homozygotic state. Pantothenate kinase-associated neurodegeneration typically manifests with generalized dystonia and psychiatric symptoms. Here, we present a Pantothenate kinase-associated neurodegeneration patient with dyslipidemia and hypercalciuria as potentially previously undescribed metabolic phenotype.